BioMarin Pharmaceutical, Inc. (BMRN)
64.08
+0.66
(+1.04%)
USD |
NASDAQ |
Feb 20, 16:00
64.00
-0.08
(-0.12%)
After-Hours: 20:00
BioMarin Pharmaceutical Market Cap : 12.31B for Feb. 20, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amicus Therapeutics, Inc. | 4.499B |
| Gilead Sciences, Inc. | 187.84B |
| Merck & Co., Inc. | 303.45B |
| AbbVie, Inc. | 397.33B |
| Bristol Myers Squibb Co. | 123.53B |
Market Cap Related Metrics
| PE Ratio | 24.01 |
| PS Ratio | 4.062 |
| PEG Ratio | 0.3955 |
| Price to Book Value | 2.033 |
| Price to Free Cash Flow | 15.17 |
| Price | 64.08 |
| Earnings Yield | 4.16% |
| PEGY Ratio | 0.3955 |
| Operating PE Ratio | 14.65 |
| Normalized PE Ratio | 17.96 |